Logo image of MTX.DE

MTU AERO ENGINES AG (MTX.DE) Stock Fundamental Analysis

FRA:MTX - DE000A0D9PT0 - Common Stock

360.8 EUR
-0.7 (-0.19%)
Last: 9/11/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MTX. MTX was compared to 41 industry peers in the Aerospace & Defense industry. MTX has only an average score on both its financial health and profitability. MTX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year MTX was profitable.
MTX had a positive operating cash flow in the past year.
Of the past 5 years MTX 4 years were profitable.
Each year in the past 5 years MTX had a positive operating cash flow.
MTX.DE Yearly Net Income VS EBIT VS OCF VS FCFMTX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

The Return On Assets of MTX (7.23%) is better than 90.24% of its industry peers.
MTX has a better Return On Equity (22.17%) than 85.37% of its industry peers.
MTX's Return On Invested Capital of 10.39% is fine compared to the rest of the industry. MTX outperforms 65.85% of its industry peers.
Industry RankSector Rank
ROA 7.23%
ROE 22.17%
ROIC 10.39%
ROA(3y)2.55%
ROA(5y)2.41%
ROE(3y)8.72%
ROE(5y)7.98%
ROIC(3y)N/A
ROIC(5y)N/A
MTX.DE Yearly ROA, ROE, ROICMTX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

With an excellent Profit Margin value of 10.44%, MTX belongs to the best of the industry, outperforming 87.80% of the companies in the same industry.
In the last couple of years the Profit Margin of MTX has declined.
MTX has a better Operating Margin (12.25%) than 75.61% of its industry peers.
MTX's Operating Margin has declined in the last couple of years.
MTX's Gross Margin of 16.90% is on the low side compared to the rest of the industry. MTX is outperformed by 73.17% of its industry peers.
MTX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 12.25%
PM (TTM) 10.44%
GM 16.9%
OM growth 3Y17.54%
OM growth 5Y-3.69%
PM growth 3Y17.24%
PM growth 5Y-3.73%
GM growth 3Y6.66%
GM growth 5Y-3.81%
MTX.DE Yearly Profit, Operating, Gross MarginsMTX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MTX is still creating some value.
MTX has about the same amout of shares outstanding than it did 1 year ago.
MTX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MTX has a worse debt to assets ratio.
MTX.DE Yearly Shares OutstandingMTX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MTX.DE Yearly Total Debt VS Total AssetsMTX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

MTX has an Altman-Z score of 3.03. This indicates that MTX is financially healthy and has little risk of bankruptcy at the moment.
MTX has a Altman-Z score of 3.03. This is in the better half of the industry: MTX outperforms 68.29% of its industry peers.
MTX has a debt to FCF ratio of 19.44. This is a negative value and a sign of low solvency as MTX would need 19.44 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 19.44, MTX is doing worse than 75.61% of the companies in the same industry.
A Debt/Equity ratio of 0.56 indicates that MTX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.56, MTX is in line with its industry, outperforming 53.66% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 19.44
Altman-Z 3.03
ROIC/WACC1.56
WACC6.65%
MTX.DE Yearly LT Debt VS Equity VS FCFMTX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

MTX has a Current Ratio of 1.39. This is a normal value and indicates that MTX is financially healthy and should not expect problems in meeting its short term obligations.
MTX has a Current ratio of 1.39. This is in the better half of the industry: MTX outperforms 75.61% of its industry peers.
A Quick Ratio of 1.04 indicates that MTX should not have too much problems paying its short term obligations.
MTX has a better Quick ratio (1.04) than 80.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.04
MTX.DE Yearly Current Assets VS Current LiabilitesMTX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.03% over the past year.
The Earnings Per Share has been growing slightly by 6.33% on average over the past years.
MTX shows a strong growth in Revenue. In the last year, the Revenue has grown by 44.23%.
The Revenue has been growing by 9.87% on average over the past years. This is quite good.
EPS 1Y (TTM)42.03%
EPS 3Y29.94%
EPS 5Y6.33%
EPS Q2Q%41.12%
Revenue 1Y (TTM)44.23%
Revenue growth 3Y20.95%
Revenue growth 5Y9.87%
Sales Q2Q%17.76%

3.2 Future

Based on estimates for the next years, MTX will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.76% on average per year.
The Revenue is expected to grow by 11.11% on average over the next years. This is quite good.
EPS Next Y24.68%
EPS Next 2Y15.85%
EPS Next 3Y13.84%
EPS Next 5Y13.76%
Revenue Next Year16.08%
Revenue Next 2Y12.75%
Revenue Next 3Y11.9%
Revenue Next 5Y11.11%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MTX.DE Yearly Revenue VS EstimatesMTX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B
MTX.DE Yearly EPS VS EstimatesMTX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20 25

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.88, which indicates a rather expensive current valuation of MTX.
Compared to the rest of the industry, the Price/Earnings ratio of MTX indicates a rather cheap valuation: MTX is cheaper than 90.24% of the companies listed in the same industry.
MTX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.44, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 19.15 indicates a rather expensive valuation of MTX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MTX indicates a rather cheap valuation: MTX is cheaper than 82.93% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, MTX is valued at the same level.
Industry RankSector Rank
PE 21.88
Fwd PE 19.15
MTX.DE Price Earnings VS Forward Price EarningsMTX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MTX indicates a rather cheap valuation: MTX is cheaper than 80.49% of the companies listed in the same industry.
MTX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. MTX is more expensive than 68.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 154.11
EV/EBITDA 13.68
MTX.DE Per share dataMTX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MTX's earnings are expected to grow with 13.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.89
PEG (5Y)3.46
EPS Next 2Y15.85%
EPS Next 3Y13.84%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.60%, MTX is not a good candidate for dividend investing.
MTX's Dividend Yield is comparable with the industry average which is at 1.19.
Compared to an average S&P500 Dividend Yield of 2.45, MTX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.6%

5.2 History

The dividend of MTX decreases each year by -5.03%.
Dividend Growth(5Y)-5.03%
Div Incr Years0
Div Non Decr Years3
MTX.DE Yearly Dividends per shareMTX.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

MTX pays out 15.38% of its income as dividend. This is a sustainable payout ratio.
DP15.38%
EPS Next 2Y15.85%
EPS Next 3Y13.84%
MTX.DE Yearly Income VS Free CF VS DividendMTX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
MTX.DE Dividend Payout.MTX.DE Dividend Payout, showing the Payout Ratio.MTX.DE Dividend Payout.PayoutRetained Earnings

MTU AERO ENGINES AG

FRA:MTX (9/11/2025, 7:00:00 PM)

360.8

-0.7 (-0.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-24 2025-07-24/dmh
Earnings (Next)10-23 2025-10-23/amc
Inst Owners75.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.42B
Analysts74.17
Price Target395.12 (9.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.6%
Yearly Dividend2.18
Dividend Growth(5Y)-5.03%
DP15.38%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.07%
Min EPS beat(2)13.94%
Max EPS beat(2)16.19%
EPS beat(4)4
Avg EPS beat(4)8.2%
Min EPS beat(4)0.12%
Max EPS beat(4)16.19%
EPS beat(8)6
Avg EPS beat(8)4.51%
EPS beat(12)8
Avg EPS beat(12)5.49%
EPS beat(16)11
Avg EPS beat(16)4.95%
Revenue beat(2)2
Avg Revenue beat(2)4.21%
Min Revenue beat(2)2.45%
Max Revenue beat(2)5.98%
Revenue beat(4)3
Avg Revenue beat(4)2.12%
Min Revenue beat(4)-2.25%
Max Revenue beat(4)5.98%
Revenue beat(8)4
Avg Revenue beat(8)0.11%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.08%
PT rev (3m)15.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)28.27%
EPS NY rev (1m)9.72%
EPS NY rev (3m)9.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)1.28%
Valuation
Industry RankSector Rank
PE 21.88
Fwd PE 19.15
P/S 2.38
P/FCF 154.11
P/OCF 24.96
P/B 5.05
P/tB 8.04
EV/EBITDA 13.68
EPS(TTM)16.49
EY4.57%
EPS(NY)18.84
Fwd EY5.22%
FCF(TTM)2.34
FCFY0.65%
OCF(TTM)14.46
OCFY4.01%
SpS151.65
BVpS71.4
TBVpS44.85
PEG (NY)0.89
PEG (5Y)3.46
Profitability
Industry RankSector Rank
ROA 7.23%
ROE 22.17%
ROCE 14.48%
ROIC 10.39%
ROICexc 15.22%
ROICexgc 21.84%
OM 12.25%
PM (TTM) 10.44%
GM 16.9%
FCFM 1.54%
ROA(3y)2.55%
ROA(5y)2.41%
ROE(3y)8.72%
ROE(5y)7.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y53.54%
ROICexcg growth 5Y11.08%
ROICexc growth 3Y47.75%
ROICexc growth 5Y8.65%
OM growth 3Y17.54%
OM growth 5Y-3.69%
PM growth 3Y17.24%
PM growth 5Y-3.73%
GM growth 3Y6.66%
GM growth 5Y-3.81%
F-Score6
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 19.44
Debt/EBITDA 1.57
Cap/Depr 174.33%
Cap/Sales 7.99%
Interest Coverage 250
Cash Conversion 56.62%
Profit Quality 14.79%
Current Ratio 1.39
Quick Ratio 1.04
Altman-Z 3.03
F-Score6
WACC6.65%
ROIC/WACC1.56
Cap/Depr(3y)170.27%
Cap/Depr(5y)151.83%
Cap/Sales(3y)8.23%
Cap/Sales(5y)7.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.03%
EPS 3Y29.94%
EPS 5Y6.33%
EPS Q2Q%41.12%
EPS Next Y24.68%
EPS Next 2Y15.85%
EPS Next 3Y13.84%
EPS Next 5Y13.76%
Revenue 1Y (TTM)44.23%
Revenue growth 3Y20.95%
Revenue growth 5Y9.87%
Sales Q2Q%17.76%
Revenue Next Year16.08%
Revenue Next 2Y12.75%
Revenue Next 3Y11.9%
Revenue Next 5Y11.11%
EBIT growth 1Y542.48%
EBIT growth 3Y42.17%
EBIT growth 5Y5.82%
EBIT Next Year52.17%
EBIT Next 3Y20.92%
EBIT Next 5Y18.16%
FCF growth 1Y-53.68%
FCF growth 3Y-41.04%
FCF growth 5Y-35.95%
OCF growth 1Y8.51%
OCF growth 3Y7.99%
OCF growth 5Y-3.01%